Background and aims: Inflammatory bowel disease is associated with increased risk of cholelithiasis. However, the histologic patterns in gallbladders have not been extensively studied. This study is designed to characterize the histopathologic features of cholecystectomy specimens in inflammatory bowel disease patients, compared to a control group. Methods: Cholecystectomy specimens in 78 Crohn's disease patients and 50 ulcerative colitis patients were reviewed. These were compared with 93 cholecystomies from noninflammatory bowel disease patients of approximate age and sex. The pattern and extent of inflammation was noted. Results: Marked chronic cholecystitis was present in 12% of ulcerative colitis patients (P b 0.05) and 10.3% of Crohn's disease patients (P N 0.05), compared to 4.3% of the noninflammatory bowel disease control group. Eight percent of ulcerative colitis patients (P b 0.05) and 2.6% of Crohn's disease patients (P N 0.05) had acute serositis, compared to 0% of the noninflammatory bowel disease control. The third inflammatory pattern, nodular lymphoid aggregates, was significantly increased in Crohn's disease patients after adjusting for the effect of cholelithiasis. Nodular lymphoid aggregates were found in 21.2% of Crohn's disease patients and 9.7% of ulcerative colitis patients without cholelithiasis, compared to 5% of noninflammatory bowel disease controls without cholelithiasis, a statistically significant difference between the Crohn's disease and control groups (P b 0.05). Conclusions: Inflammatory bowel disease patients show similar inflammatory patterns in cholecystectomy specimens compared to the general population. However, two inflammatory patterns that
Introduction
Inflammatory bowel disease (IBD) is commonly associated with cholelithiasis, particularly in patients with Crohn's disease (CD), [1] [2] [3] [4] the incidence ranging from 13 to 34%. Although the association between cholelithiasis and ulcerative colitis (UC) is unclear, in some studies there appear to be an increased risk of cholelithiasis in UC patients when compared to the general population. 1, 2 Extraintestinal manifestations have been traditionally emphasized in CD, but not in UC, which has been thought of as a pure colonic disease except for limited terminal ileal inflammation (backwash ileitis). In recent years, however, UCassociated upper gastrointestinal inflammation has been reported and studied as part of an extraintestinal presentation of UC. [5] [6] [7] To our knowledge, patterns of inflammation in cholecystectomy specimens in patients with IBD are not well described. Thus, we designed the current study to assess patterns of inflammation in gallbladder specimens in both UC and CD patients and compared these findings to those in cholecystectomy specimens from age-and sex-matched control patients.
Materials and methods

Patients
Seventy-eight CD and 50 UC patients, clinically diagnosed and biopsy-confirmed, who had cholecystectomies at Cleveland Clinic, were identified from an IBD database maintained by the Department of Gastroenterology. This study was approved by the Institutional Review Board of the Cleveland Clinic. Among the 78 CD patients, 58 (74.4%) were female with a mean age of 45.1 years (range, 18-79 years; Table 1 ). Among the 50 UC patients, 28 (56%) were female with a mean age of 44.7 years (range, 18-73 years). These two groups were compared with 93 cholecystectomy specimens from age-and sex-matched non-IBD control patients, which were also identified from the database in the Department of Gastroenterology. These patients pursued surgical treatment complaint of abdominal pain, with or without symptoms of nausea, vomiting, fever, or jaundice, and the clinical diagnoses of non-IBD were confirmed. Among the controls, 50 (53.8%) were female, with a mean age of 45 years (range, 18-83 years). Seven UC patients had primary sclerosing cholangitis (PSC), among them two had liver transplantation due to PSC-induced cirrhosis, and two developed cholangiocarcinoma. One UC patient had focal lowgrade dysplasia in the gallbladder. One control patient had multifocal high-grade dysplasia in the gallbladder, but no patients in this study had gallbladder adenocarcinoma.
The cholecystectomy specimens were grossed by many staff, including rotating residents and pathologist assistants, according to the standardized procedure. Representative sections of the cystic duct, fundus, and neck were submitted for histologic evaluation, if there were no additional discrete lesions appreciated grossly. Six cholecystectomy specimens were excluded from the study due to complete denudation of the gallbladder epithelium, including one patient with CD who had coexisting PSC and underwent liver transplantation.
Histologic assessment
All cholecystectomy specimens were reviewed by two gastrointestinal pathologists (JL and JRG) side by side, who were blinded to the patients' clinical diagnosis. An agreement had been reached between them for each case. The following histologic features were assessed: presence or absence of acute cholecystitis, chronic cholecystitis (mild or marked), cholelithiasis, cholesterolosis, serositis, intestinal metaplasia, pyloric gland metaplasia, nodular lymphoid aggregates, polyps, mucosal ulceration, granulomas, and perforation.
Acute serositis is characterized by collections of neutrophils in the serosa (Fig. 1A) . The criteria to define mild and marked chronic cholecystitis depend on the extents and involvement of chronic inflammation in the gallbladder. Most cholecystectomy specimens had focal small pockets or clusters of lymphoplasmacytic infiltrates that fitted the definition of mild chronic cholecystitis (Fig. 1B) . If the involvement was diffuse and the extent was prominent marked chronic cholecystitis was indicated (Fig. 1C) . Nodular lymphoid aggregates are typified by a few or multiple clusters of lymphocytes, which are either located in the lamina propria, the muscle wall or throughout the full thickness of gallbladder ( Fig. 1D ) 
Statistical analysis
Statistical analyses were performed using the chi-square test, with a P value b 0.05 being considered statistically significant.
Results
The histologic findings in cholecystectomy specimens from patients with UC, CD, and non-IBD patients are summarized in Table 2 . Cholelithiasis was found to be quite common and was identified in 34.5% and 57.7% of patients with UC and CD, respectively. This was not found to be significantly different from the prevalence of cholelithiasis in non-IBD controls (55.9%). Both chronic cholecystitis and acute serositis were significantly more common in UC and CD patients when compared to the non-IBD control patients (Fig. 1) . Marked chronic cholecystitis was present in 12% of UC patients (P = 0.039) and 10.3% of CD patient (P N 0.05), compared to 4.3% of the non-IBD control group. Eight percent of UC patients (P = 0.006) and 2.6% of CD patients (P N 0.05) Figure 1 The patterns of inflammation in cholecystectomies of patients with inflammatory bowel disease. 1A: acute serositis is characterized by collections of neutrophils in the serosa (× 200). 1B and 1C: chronic cholecystitis is characterized by infiltrates of variable amounts of inflammatory cells, including lymphocytes, plasma cells, eosinophils, and mast cells. According to the extent and involvement of chronic inflammation, chronic cholecystitis is divided into mild (1B, ×100) and marked chronic cholecystitis (1C, × 100). 1D: Nodular lymphoid aggregates are typified by a few or multiple clusters of lymphocytes, which can either locate in the lamina propria, in the smooth muscle wall or throughout the full thickness of gallbladder (×100). had acute serositis, compared to none in the non-IBD control group. All other assessed histologic features, including cholesterolosis, intestinal metaplasia, pyloric gland metaplasia, polyps, mucosal ulceration, granulomas, and gallbladder perforation, were not found to be significantly different among the three groups of patients. Cholelithiasis itself is a well-established proinflammatory factor. After adjusting for the complication of cholelithiasisinduced inflammation in cholecystectomy specimens, IBD and non-IBD patients were further subdivided into cholelithiasis and noncholelithiasis subpopulations. As shown in Table 3 , IBD patients without cholelithiasis more commonly had nodular lymphoid aggregates (21.2% in CD patients and 9.7% of UC patients), compared to 5% of non-IBD control patients without cholelithiasis, a statistically significant difference between the CD and control groups (P b 0.05). Nodular lymphoid aggregates were noted either in the lamina propria, the smooth muscle wall, or throughout the full thickness of the gallbladder wall (Fig. 1D ).
Discussion
Besides inflammatory complications in the upper gastrointestinal tract, cholelithiasis is also common in IBD patients, particularly in those with CD. [1] [2] [3] [4] However, the association between cholelithiasis and UC is less clear. In the current study, we found gallstones to be common in IBD patients, including 34.5% of patients with UC and 57.7% of patients with CD. This, however, was not significantly different from the prevalence of gallstones in non-IBD controls (55.9%) in this study. Because of our study design, we could not precisely define the incidence of cholelithiasis in patients with either UC or CD compared to the general population. The incidence of cholelithiasis in the current study only reveals the frequency of gallstones of IBD patients who had cholecystectomies performed at a tertiary medical center. The control subjects who were indeed seeking medical attention for abdominal complaints and symptoms demonstrated a higher incidence of cholelithiasis than in the general population.
In the current study, we found 73.4% of IBD patients had cholecystomies as a solo urgent surgical treatment for symptom relief, while the remainder was performed as elective operation in addition to another procedure, such as subtotal/total colectomy, small bowel resection, ileostomy takedown, liver transplantation, fistula repair, or lysis of adhesions. Gallbladder imaging is recommended as part of the preoperative workup and follow-up of ileostomies in IBD patients who have abdominal symptoms or are candidates for abdominal surgery. 8 The low threshold to perform cholecystectomy in IBD patients might prevent the progression of chronic inflammation, thus aborting the full development of biliary epithelial dysplasia and its associated malignancy.
Although IBD is well known to be associated with increased risk of cholelithiasis, the etiology is not clear. Loss of function of the terminal ileum due to resection or chronic inflammation is thought to contribute to disturbed enterohepatic circulation of bile acid, leading to its depletion. The decrease in the bile acid pool may cause precipitation of cholesterol, initially as crystal and subsequently as cholesterol stones. 8, 9 An additional potential mechanism could be colonization of the terminal ileum by anaerobic bacteria, resulting in deconjugation of bile acids to products that are less well absorbed and have an irritating effect on the mucosa of the gallbladder. 10 The current study does not offer any additional information as to the cause or causes of cholelithiasis in IBD.
Although there are some studies assessing inflammatory patterns in gallbladder specimens from patients with IBD, a detailed histologic assessment comparing patients with UC, CD, and non-IBD controls has not yet been published, to our knowledge. In the current study, we thoroughly investigated inflammatory patterns in the gallbladder of IBD patients. Two inflammatory patterns in UC and one pattern in CD, after stratifying for the effect of cholelithiasis, were found to occur more often than in the non-IBD controls. Patients with UC were significantly more likely to show chronic cholecystitis and acute serositis than non-IBD controls, whereas CD patients without cholelithiasis were more likely to harbor nodular lymphoid aggregates than non-IBD controls without cholelithiasis.
If one assumes that inflammatory patterns in the gallbladder would mimic those seen in the tubal gut, then one might expect nodular lymphoid aggregates and granulomas to be significantly more common in patients with CD when compared to UC patients or non-IBD controls. Nodular lymphoid aggregates were found with a similar prevalence in all three groups, with a range from 10.8% in non-IBD controls to 15.4% in patients with CD. Small noncaseating granulomas were exceedingly rare in all three groups, including those with CD. No granulomas with transmural distribution were seen in any of these groups. The association of acute serositis in patients with UC is an unusual finding, as full thickness inflammation is generally absent in the tubular gastrointestinal tract in UC patients. A recent study demonstrated that the presence of concomitant inflammatory bowel disease was related with an increased risk of post-cholecystectomy infectious complication. 11 Although not fully clear, the significance of acute serositis might be associated with post-cholecystectomy infection. Furthermore, as shown in this paper, the presence of inflammation in the noncholelithiasis subgroup of IBD patients indicates that other noncholelithiasis, proinflammatory factors take part in the inflammatory process in the gallbladder.
Conclusion
This study emphasizes that inflammatory involvement in gallbladder is common in patients with IBD. From the pathogenetic perspective, these inflammatory changes may not represent isolated changes, but rather could be a manifestation of more generalized mucosal inflammation in IBD.
